Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1971 1
1972 3
1973 5
1974 1
1975 4
1976 10
1977 5
1978 3
1979 5
1980 5
1981 3
1982 4
1983 5
1984 7
1985 12
1986 6
1987 6
1988 7
1989 6
1990 5
1991 4
1992 8
1993 10
1994 9
1995 9
1996 6
1997 5
1998 12
1999 8
2000 8
2001 14
2002 9
2003 9
2004 10
2005 6
2006 11
2007 8
2008 8
2009 17
2010 11
2011 9
2012 8
2013 21
2014 20
2015 17
2016 10
2017 19
2018 13
2019 14
2020 13
2021 10
2022 16
2023 15
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Results by year

Filters applied: . Clear all
Page 1
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
Munir T, Cairns DA, Bloor A, Allsup D, Cwynarski K, Pettitt A, Paneesha S, Fox CP, Eyre TA, Forconi F, Elmusharaf N, Kennedy B, Gribben J, Pemberton N, Sheehy O, Preston G, Schuh A, Walewska R, Duley L, Howard D, Hockaday A, Jackson S, Greatorex N, Girvan S, Bell S, Brown JM, Webster N, Dalal S, de Tute R, Rawstron A, Patten PEM, Hillmen P; National Cancer Research Institute Chronic Lymphocytic Leukemia Subgroup. Munir T, et al. N Engl J Med. 2024 Jan 25;390(4):326-337. doi: 10.1056/NEJMoa2310063. Epub 2023 Dec 10. N Engl J Med. 2024. PMID: 38078508 Clinical Trial.
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.
Munir T, Girvan S, Cairns DA, Bloor A, Allsup D, Varghese AM, Gohil S, Paneesha S, Pettitt A, Eyre T, Fox CP, Forconi F, Kennedy B, Balotis C, Pemberton N, Sheehy O, Gribben J, Elmusharaf N, Gatto S, Preston G, Schuh A, Walewska R, Duley L, Webster N, Dalal S, Rawstron A, Howard D, Hockaday A, Jackson S, Greatorex N, Bell S, Stones D, Brown JM, Patten PEM, Hillmen P; UK CLL Trials Group. Munir T, et al. N Engl J Med. 2025 Sep 25;393(12):1177-1190. doi: 10.1056/NEJMoa2504341. Epub 2025 Jun 15. N Engl J Med. 2025. PMID: 40521799 Free article. Clinical Trial.
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
Russell NH, Wilhelm-Benartzi C, Othman J, Dillon R, Knapper S, Batten LM, Canham J, Hinson EL, Betteridge S, Overgaard UM, Gilkes A, Potter N, Mehta P, Kottaridis P, Cavenagh J, Hemmaway C, Arnold C, Freeman SD, Dennis M; PORTEC Study Group. Russell NH, et al. J Clin Oncol. 2024 Apr 1;42(10):1158-1168. doi: 10.1200/JCO.23.00943. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215358 Free PMC article. Clinical Trial.
Confronting therapeutic ignorance.
Chalmers I. Chalmers I. BMJ. 2008 Jul 16;337:a841. doi: 10.1136/bmj.39555.392627.80. BMJ. 2008. PMID: 18632679 No abstract available.
Reflections on the history of systematic reviews.
Clarke M, Chalmers I. Clarke M, et al. Among authors: chalmers i. BMJ Evid Based Med. 2018 Aug;23(4):121-122. doi: 10.1136/bmjebm-2018-110968. Epub 2018 Jun 19. BMJ Evid Based Med. 2018. PMID: 29921711 No abstract available.
Promoting critical appraisal skills.
Elessi K, Albarqouni L, Glasziou P, Chalmers I. Elessi K, et al. Among authors: chalmers i. Lancet. 2019 Jun 29;393(10191):2589-2590. doi: 10.1016/S0140-6736(19)30346-0. Epub 2019 Jun 27. Lancet. 2019. PMID: 31258125 No abstract available.
The James Lind Initiative.
Chalmers I. Chalmers I. J R Soc Med. 2003 Dec;96(12):575-6. doi: 10.1177/014107680309601201. J R Soc Med. 2003. PMID: 14645604 Free PMC article. No abstract available.
Ultra-low noise, bi-polar, programmable current sources.
Mrozowski MS, Chalmers IC, Ingleby SJ, Griffin PF, Riis E. Mrozowski MS, et al. Among authors: chalmers ic. Rev Sci Instrum. 2023 Jan 1;94(1):014701. doi: 10.1063/5.0114760. Rev Sci Instrum. 2023. PMID: 36725565 Free article.
461 results